By Precious Okure-Asamoah
The Food and Drugs Authority (FDA), has released a statement on the unregistered Turkish brand of Galus Met Tablet (Vidalipin Metformin Hydrochloride 50 mg/1000 mg) being sold in some pharmacies in Ghana.
The FDA is cautioning the public that the affected products with only Turkish inscriptions have not been registered.
The FDA, in a statement, announced that efforts are being made to remove the products from pharmacies where they were detected.
It also indicated that importers and retailers of the pharmaceutical products are to immediately stop supplying all the batches and return any stock to the nearest FDA office for safe disposal.
The FDA also stated that it is taking the necessary regulatory actions to prevent any future occurrence and that it ”will not hesitate to apply the strictest sanctions, including criminal prosecution and imposition of administrative fines, to any individual or facility found to be importing or distributing such products”.
FDA reminds all that ”all products marketed in Ghana must be labelled in or translated into English”.
